Recent news on Rdna Origin

Hypoglycemia: Answering the Challenge With Long-acting Insulin Analogs  -  May 18, 2007
Medscape (subscription)Re: Discontinuation of Humulin [R]U ULTRALENTE [R] (human insulin [rDNA origin] extended zinc suspension) and Humulin [R]L LENTE [R] (human insulin [rDNA

Sopranos Star Aida Turturro Speaks out to Encourage Fellow ...  -  May 8, 2007
Elites TV,Then, about three years ago, we added Lantus (insulin glargine [rDNA origin] injection), a once-daily, long-acting insulin to my treatment plan.

NPS Reports First Quarter 2007 Financial Results and Progress in ...  -  May 9, 2007
PR Newswire (press release),NPS is continuing to support the investigator-led Phase 2 study of PREOS(R) (full-length parathyroid hormone [rDNA origin] for injection) as PTH replacement

Innovative Pulmonary & PEGylation-based Therapeutic Product ...  -  Apr 14, 2007
Medical News Today (press release),Partnered with Pfizer, Nektar developed the core technologies used for Exubera®(insulin human [rDNA origin] Inhalation Powder), including the formulation

Smart drug devices  -  Mar 25, 2007
Express Pharma,Developed in a joint effort by Aventis and Pfizer, Exubera is an insulin rDNA origin powder for oral inhalation. Indicated for the treatment of adults with

Euro RSCG Life LM&P Wins Pfizer Xalatan(R) Account  -  Mar 21, 2007
PR-Inside.com (Pressemitteilung),Xalatan joins a portfolio of Pfizer products handled by LM&P including Chantix(TM) (varenicline); Genotropin(R) (somatropin {rDNA origin} for injection);

NPS Pharmaceuticals (NPSP) Tops Q4 EPS by 6c, Announces Restructuring  -  Mar 14, 2007
StreetInsider.com (subscription),...a new business plan to advance its late-stage product candidates, PREOS (full-length parathyroid hormone [rDNA origin] for injection) and teduglutide.

Can Generic Biologics Be Approved Through an Abbreviated Process?  -  Mar 20, 2007
Atlantic Information Services, Inc.,When FDA approved the growth hormone Omnitrope (somatropin rDNA origin) in May 2006, it did so under Sec. 505(b)(2) of the federal Food, Drug, and Cosmetic

World's first digital insulin pen with memory  -  Feb 27, 2007
In-PharmaTechnologist.com,HumaPen Memoir is intended for use with Lilly's Humalog (insulin lispro injection [rDNA origin]), for diabetes sufferers who need to repeatedly administer

Lilly Introduces World's First Digital Insulin Pen With Memory  -  Feb 25, 2007
SpiritIndia,MEMOIR is now available by prescription in pharmacies nationwide for use with Humalog® (insulin lispro injection [rDNA origin]), the most-prescribed

Nektar Announces Financial Results for the Year and Fourth Quarter ...  -  Mar 1, 2007
PharmaLive.com (press release),Revenue for 2006 related to Exubera(R) (insulin human (rDNA origin)) Inhalation Powder was $110.2 million. As of December 31, 2006, Nektar had cash,

New insulin pen with digital memory simplifies diabetes management  -  Feb 25, 2007
SpiritIndia,Both MEMOIR and LUXURA HD are for use with Humalog(R), (insulin lispro injection [rDNA origin]) the most-prescribed mealtime insulin in the US.

FDA Approves NovoLog(R) (Insulin Aspart [rDNA Origin] Injection ...  -  Jan 30, 2007
DG News2007 -- Novo Nordisk announced today that the United States Food and Drug Administration (FDA) has approved NovoLog(R) (insulin aspart [rDNA origin]

NEW INSULIN PEN IS FIRST WITH DIGITAL MEMORY; MAY HELP SIMPLIFY ...  -  Feb 21, 2007
PR Newswire (press release),Both MEMOIR and LUXURA HD are for use with Humalog®, (insulin lispro injection [rDNA origin]) the most-prescribed mealtime insulin in the US.

NovoLog Receives Pregnancy Category B Rating  -  Jan 31, 2007
Facts and Comparisons,The FDA has approved Novo Nordisk’s NovoLog (insulin aspart [rDNA origin]) injection with a pregnancy Category B rating. Adequate studies conducted in

Merck-Serono launches electronic growth hormone injection device  -  Jan 30, 2007
In-PharmaTechnologist.com,Intended for use with the company's Saizen (somatropin (rDNA origin) for injection) therapy, it is the latest product in the firm's drive to develop

FDA Approves NovoLog(R) Category Change for Use in Pregnant Women ...  -  Jan 30, 2007
Drug Newswire (press release),...the United States Food and Drug Administration (FDA) has approved NovoLog(R) (insulin aspart [rDNA origin] injection) for pregnancy Category B rating,

Lilly Announces Strategic Changes to its Global Manufacturing ...  -  Jan 11, 2007
PR Newswire (press release),...is available at http://www.lilly.com. C-LLY Humalog(R) (insulin lispro [rDNA origin] injection) (Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO)

Lilly to change global manufacturing operations  -  Jan 14, 2007
News-Medical.net,...which includes new bulk capacity for Humalog (insulin lispro [rDNA origin] injection), Lilly's first-in-class rapid acting insulin analog.

Nektar Appoints Howard W. Robin President and CEO  -  Jan 8, 2007
PharmaLive.com (press release),..."Clearly, with the recent launch of Exubera(R) (insulin human (rDNA origin)) Inhalation Powder, easily the most innovative product to enter the diabetes

Nastech Announces Positive Phase 1 Clinical Results Of Insulin ...  -  Dec 7, 2006
Medical News Today (press release),...spray formulations, NovoLog insulin aspart (rDNA origin) injection and Exubera (insulin human [rDNA origin]) Inhalation Powder in healthy subjects.

New Humatrope Indication  09 Nov 2006
The FDA has approved Lilly’s SNDA for Humatrope (somatropin [rDNA origin] for injection) for the treatment of short stature or growth failure in children ... -Facts and Comparisons, NPS Pharmaceuticals Reports Third Quarter and Nine Month Results  09 Nov 2006
Business and Pipeline Update << NPS reported progress for the following key milestones: -- PREOS(R)/Preotact(R) (parathyroid hormone [rDNA origin] for injection ... -CNW Telbec (Communiqués de presse), GenSci Expects Topical Molgramostim Gel Approval in 2007  Nov 3, 2006
The active ingredient in Genfulin(TM) is molgramostim (human granulocyte-macrophage colony stimulating factor, hGM-CSF (rDNA origin). ... -Genetic Engineering News (press release), Market Report -- In Play (NVO)  Oct 27, 2006
...by 52%; sales of NovoSeven Coagulation Factor VIIa (Recombinant) increased by 13%; sales of Norditropin (somatropin [rDNA origin] injection) increased by 21 ... -MSN Money Novo Nordisk Announces Financial Statement for the First Nine ...  Oct 27, 2006
...by 52% - Sales of NovoSeven(R) Coagulation Factor VIIa (Recombinant) increased by 13% - Sales of Norditropin(R) (somatropin [rDNA origin] injection) increased ... -MSN Money Novo Nordisk Announces Financial Statement for the First Nine ...  Oct 27, 2006
...by 52% - Sales of NovoSeven® Coagulation Factor VIIa (Recombinant) increased by 13% - Sales of Norditropin® (somatropin [rDNA origin] injection) increased by ... -Yahoo! News (press release) Inhaled Human Insulin Comparable to Injectable Insulin in Type 1 ...  Sep 21, 2006
...[Presentation title: Pharmacologic Reproducibility of Prandial Inhaled Human Insulin (Exubera [insulin human {rDNA origin}] Inhalation Powder) in Subjects with ... -DG News

Zelos and Nektar Announce Start of Phase 1 Trial of Inhaled ...  Sep 21, 2006
Exubera(R) (insulin human (rDNA origin)) Inhalation Powder, which has been approved in the US, European Union, Brazil and Mexico, is the most advanced product ... -Genetic Engineering News

Nastech Initiates Clinical Development of Rapid Acting Insulin ...  Sep 19, 2006
...- Phase I pharmacokinetic study to compare Nastech's intranasal insulin to injectable insulin and Exubera(R) (insulin human [rDNA origin]) Inhalation Powder ... -PR Newswire

Nastech Pharmaceutical's Intranasal Insulin Formulation Enters ...  Sep 19, 2006
...s intranasal formulation to an approved injectable product and to a recently approved new dosage form, Exubera® (insulin human [rDNA origin]) Inhalation Powder ... -Genetic Engineering News

Nastech Initiates Clinical Development of Rapid Acting Insulin ...  Sep 19, 2006
...intranasal formulation to an approved injectable product and to a recently approved new dosage form, Exubera(R) (insulin human [rDNA origin]) Inhalation Powder ... -PharmaLive.com

Exubera Effective In Diabetes Patients Who Have Respiratory ...  Sep 15, 2006
Adult patients with diabetes who took Exubera(R) (insulin human [rDNA origin]) inhalation powder were able to safely maintain good blood sugar control even if ... -Medical News Today

Nektar Reports that Pfizer Announced New Analyses Showing that ...  Sep 14, 2006
DENMARK -- September 14, 2006 -- Nektar Therapeutics reported today that Pfizer announced that new Exubera® (insulin human (rDNA origin)) Inhalation Powder ... -DG News

Exubera Effective in Diabetes Patients who Have Respiratory ...  Sep 14, 2006
...a Respiratory Infection Than Patients Using Injectable Insulin.' Adult patients with diabetes who took Exubera(R) (insulin human [rDNA origin]) were able to ... -campus med

Exubera Effective in Diabetes Patients who Have Respiratory ...  Sep 14, 2006
14 /PRNewswire-FirstCall/ -- Adult patients with diabetes who took Exubera® (insulin human [rDNA origin]) inhalation powder were able to safely maintain good ... -Yahoo! News

Exubera Effective in Diabetes Patients who Have Respiratory ...  Sep 14, 2006
COPENHAGEN, Denmark | Sep 14, 2006 | Adult patients with diabetes who took Exubera® (insulin human [rDNA origin]) inhalation powder were able to safely ... -PipelineReview.com

Nektar Reports that Pfizer Announced New Analyses Showing that ...  Sep 14, 2006
Nektar Therapeutics (Nasdaq:NKTR) reported today that Pfizer announced that new Exubera(R) (insulin human (rDNA origin)) Inhalation Powder data were being ... -Genetic Engineering News

Exubera Effective in Diabetes Patients Who Have Respiratory ...  Sep 14, 2006
Denmark, September 14, 2006 /PRNewswire-FirstCall/ -- Adult patients with diabetes who took Exubera(R) (insulin human [rDNA origin]) inhalation powder were ... -PharmaLive.com

Nektar Reports that Pfizer Announced New Analyses Showing that ...  Sep 14, 2006
Sep 14, 2006 - Nektar Therapeutics (Nasdaq:NKTR) reported today that Pfizer announced that new Exubera(R) (insulin human (rDNA origin)) Inhalation Powder data ... -PharmaLive.com

Tercica to Present at the BioCentury and Thomson Financial ...  Sep 1, 2006
The company's first product, Increlex(TM) (mecasermin (rDNA origin) injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the ... -PharmaLive.com

Nastech Announces Positive Phase 1 Clinical Results Of Insulin ...  -  Dec 7, 2006
Medical News Today (press release),...spray formulations, NovoLog insulin aspart (rDNA origin) injection and Exubera (insulin human [rDNA origin]) Inhalation Powder in healthy subjects.

Serono Announces Results From Pivotal Phase III Clinical Trial of ...  Aug 17, 2006
...injection), Luveris(R) (lutropin alfa), Ovidrel Prefilled Syringe(R) (choriogonadotropin alfa injection), Serostim(R) [somatropin (rDNA origin) for injection ... -PR Newswire

Get the latest news direct to your desktop  Aug 18, 2006
...for injection), Luveris® (lutropin alfa), Ovidrel Prefilled Syringe® (choriogonadotropin alfa injection), Serostim® [somatropin (rDNA origin) for injection ... -PipelineReview.com

NPS Pharmaceuticals Reports Second Quarter and Six Month Operating ...  Aug 3, 2006
...from sales of Sensipar(R)/Mimpara(R) (cinacalcet HCl) by Amgen, celebrated the European launch of PREOTACT(R) (parathyroid hormone [rDNA origin] for injection ... -CNW Telbec (Communiqués de presse)

Sanofi-Aventis Announces First Half of 2006: Sales Growth of 7.7% ...  Aug 2, 2006
...that in patients with type 2 diabetes who had failed on oral therapy alone, the long-acting insulin Lantus(R) (insulin glargine, rDNA origin) administered once ... -International News Service

Phyton Biotech Signs Development Agreement With Insmed  Aug 1, 2006
...technology to develop a manufacturing process that could be utilized to meet the future demand of IPLEX(TM) (mecasermin rinfabate [rDNA origin] injection) as ... -Medical News Today

Nektar Announces Second Quarter 2006 Results  Aug 3, 2006
Exubera(R) (insulin human (rDNA origin)) Inhalation Powder is a product from a developmental collaboration between Pfizer and Nektar; and is marketed by Pfizer ... -Genetic Engineering News

NPS Pharmaceuticals Reports Second Quarter and Six Month Operating ...  Aug 3, 2006
...from sales of Sensipar®/Mimpara® (cinacalcet HCl) by Amgen, celebrated the European launch of PREOTACT® (parathyroid hormone [rDNA origin] for injection) by ... -Yahoo! News

Nektar Closes Its Bradford UK Site; Company Focusing on ...  Jul 26, 2006
...in the near-term: (1) developing proprietary products based on our drug delivery technology; (2) Exubera(R) (insulin human (rDNA origin)) Inhalation Powder ... -PharmaLive.com

Unigene & Upsher-Smith File Patent Infringement Lawsuit  Jul 26, 2006
Drug Application (ANDA) seeking approval of a nasal spray product that claims to be a generic equivalent of Fortical calcitonin-salmon (rDNA origin) Nasal Spray ... -ag-IP-news Agency



New Long-Acting Insulin Analog Levemir(R) Now Available in United ...  Mar 28, 2006
...today announced that Levemir® (insulin detemir [rDNA origin] injection), a new long-acting basal insulin analog is now commercially available in the United ... - Yahoo! News

US Biotech Creates Custom Solutions in Record Time Using the ...  Apr 3, 2006
The company's first product, Increlex(TM) (mecasermin (rDNA origin) injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the ... - The Open Press

Unigene Begins Media Education Initiative to Promote Bone Health ...  Mar 31, 2006
Calcitonin-salmon (rDNA origin) is the active ingredient in Fortical(R), a nasal spray for the treatment of postmenopausal osteoporosis that was launched in ... - Genetic Engineering News

NPS Updates Status of PREOS(R) NDA  Mar 29, 2006
News) today provided the following update regarding the status of its new drug application (NDA) for PREOS® (parathyroid hormone [rDNA origin] for injection). ... - Yahoo! News

NPS Falls On Preos Approvable Letter; Safety Concerns Cited  Mar 10, 2006
...women with osteoporosis, but also showed a higher incidence of hypercalcemia in patients receiving Preos (parathyroid hormone [rDNA origin] for injection ... - BioWorld Online (subscription)

Insmed Completes $46 Million Public Offering; Underwriters ...  Mar 15, 2006
For further information about Insmed and IPLEX(TM) (mecasermin rinfabate(rDNA origin) injection), our FDA-approved drug for the treatment of growth failure in ... - Genetic Engineering News

NPS Receives Approvable Letter for PREOS NDA  Mar 10, 2006
US Food and Drug Administration (FDA) has determined that the company's new drug application (NDA) for PREOS(R) (parathyroid hormone [rDNA origin] for injection ... - Canada NewsWire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional